BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 17471513)

  • 1. The TGFbeta/Smad 3-signaling pathway is involved in butyrate-mediated vitamin D receptor (VDR)-expression.
    Daniel C; Schroder O; Zahn N; Gaschott T; Steinhilber D; Stein JM
    J Cell Biochem; 2007 Dec; 102(6):1420-31. PubMed ID: 17471513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
    Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG
    J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyrate-induced differentiation of Caco-2 cells is mediated by vitamin D receptor.
    Gaschott T; Werz O; Steinmeyer A; Steinhilber D; Stein J
    Biochem Biophys Res Commun; 2001 Nov; 288(3):690-6. PubMed ID: 11676498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
    Yoo YA; Kang MH; Kim JS; Oh SC
    Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel dominant negative Smad antagonists to TGFbeta signaling.
    Ho J; Chen H; Lebrun JJ
    Cell Signal; 2007 Jul; 19(7):1565-74. PubMed ID: 17360157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p38 MAPK signaling pathway is involved in butyrate-induced vitamin D receptor expression.
    Daniel C; Schröder O; Zahn N; Gaschott T; Stein J
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1220-6. PubMed ID: 15504345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targets of vitamin D receptor signaling in the mammary gland.
    Welsh J
    J Bone Miner Res; 2007 Dec; 22 Suppl 2():V86-90. PubMed ID: 18290729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mutations in Smad proteins that inhibit signaling by the transforming growth factor beta in mammalian cells.
    Prokova V; Mavridou S; Papakosta P; Petratos K; Kardassis D
    Biochemistry; 2007 Dec; 46(48):13775-86. PubMed ID: 17994767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
    Akel S; Bertolette D; Petrow-Sadowski C; Ruscetti FW
    Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel regulation of Smad3 oligomerization and DNA binding by its linker domain.
    Vasilaki E; Siderakis M; Papakosta P; Skourti-Stathaki K; Mavridou S; Kardassis D
    Biochemistry; 2009 Sep; 48(35):8366-78. PubMed ID: 19645436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of estrogen receptor beta with plasma-membrane caveola components: implication in control of vitamin D receptor.
    Gilad LA; Schwartz B
    J Mol Endocrinol; 2007 Jun; 38(6):603-18. PubMed ID: 17556531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coding sequence mediates induction of 5-lipoxygenase expression by Smads3/4.
    Seuter S; Sorg BL; Steinhilber D
    Biochem Biophys Res Commun; 2006 Oct; 348(4):1403-10. PubMed ID: 16919603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1beta impairment of transforming growth factor beta1 signaling by down-regulation of transforming growth factor beta receptor type II and up-regulation of Smad7 in human articular chondrocytes.
    Baugé C; Legendre F; Leclercq S; Elissalde JM; Pujol JP; Galéra P; Boumédiene K
    Arthritis Rheum; 2007 Sep; 56(9):3020-32. PubMed ID: 17763417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-chain fatty acids and colon cancer cells: the vitamin D receptor--butyrate connection.
    Gaschott T; Stein J
    Recent Results Cancer Res; 2003; 164():247-57. PubMed ID: 12899527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts.
    Li P; Wang D; Lucas J; Oparil S; Xing D; Cao X; Novak L; Renfrow MB; Chen YF
    Circ Res; 2008 Feb; 102(2):185-92. PubMed ID: 17991884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and activity of vitamin D receptor in the human placenta and in choriocarcinoma BeWo and JEG-3 cell lines.
    Pospechova K; Rozehnal V; Stejskalova L; Vrzal R; Pospisilova N; Jamborova G; May K; Siegmund W; Dvorak Z; Nachtigal P; Semecky V; Pavek P
    Mol Cell Endocrinol; 2009 Feb; 299(2):178-87. PubMed ID: 19133314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulating the stability of TGFbeta receptors and Smads.
    Lönn P; Morén A; Raja E; Dahl M; Moustakas A
    Cell Res; 2009 Jan; 19(1):21-35. PubMed ID: 19030025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of corepressors in aggressive androgen-independent prostate cancer cells results in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness.
    Ting HJ; Bao BY; Reeder JE; Messing EM; Lee YF
    Mol Cancer Res; 2007 Sep; 5(9):967-80. PubMed ID: 17855664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asiaticoside induces human collagen I synthesis through TGFbeta receptor I kinase (TbetaRI kinase)-independent Smad signaling.
    Lee J; Jung E; Kim Y; Park J; Park J; Hong S; Kim J; Hyun C; Kim YS; Park D
    Planta Med; 2006 Mar; 72(4):324-8. PubMed ID: 16557473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.